Chempartner Pharmatech Co., Ltd.
睿智医药
300149
Shenzhen Stock Exchange
Company Profile
Throughout 20 years of operation, ChemPartner developed an integrated service platform covering early drug discovery, preclinical research and CDMO, including biologics and chemical drugs, and accumulated competitive advantages in terms of business model, core technology, innovation capability, customer base, project experience and talent team with several core competencies: 1. Full-service, integrated R&D and manufacturing platform covering both chemical and biological drugs; 2. End-to-end service capability and rich service experience in biologics, from discovery to large-scale production; 3. An innovation driven platform that offers efficient and comprehensive service solutions in preclinical drug development; 4. High-performing team of talents; 5. Expanding high-quality client base.
Full description
ChemPartner is a world-renowned CRO/CDMO with 20 years of pharmaceutical research track records, offering integrated services from drug discovery, development, to manufacturing. Chempartner’s services include discovery chemistry, biology, pharmacology, DMPK, and toxicology as well as biologics discovery, development, and manufacturing CDMO. ChemPartner operates globally through strategically positioned laboratories, business offices, and representatives in the US, Europe and China.